使用机器学习算法预测AITL患者的一年整体存活率:一项多中心研究.
Xufei Huang1, Chunlan Zhang2, Kejia Liu3
1Fujian Provincial Key Laboratory on Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fujian, China.
Scientific reports
|October 13, 2025
概括
机器学习准确地预测了血管免疫细胞T细胞淋巴瘤 (AITL) 的1年生存率. 使用8个关键变量的Catboost模型为管理这种侵略性的血液恶性瘤提供了一个有前途的工具.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 计算生物学 计算生物学
背景情况:
- 血管免疫原性T细胞淋巴瘤 (AITL) 是一种严重的血液性恶性瘤.
- 预后不佳的患者从传统疗法中获得的治疗益处有限.
- 准确的生存预测对于指导AITL治疗决策至关重要.
研究的目的:
- 开发一种可解释的机器学习 (ML) 模型,用于预测AITL患者的1年整体存活率 (OS).
- 确定影响AITL患者生存的关键基线特征.
- 为了提高AITL管理的预测准确度.
主要方法:
- 利用中国4个中心223名AITL患者的数据.
- 开发并比较了5个ML算法,用于1年的OS预测.
- 用于特征选择的递归特征消除 (RFE) 和用于模型解释性的SHAP/LIME.
主要成果:
- Catboost模型实现了最高的预测性能,AUC为0.8277.
- 在RFE查后,一个具有8个关键变量的模型显示出强大的预测能力 (AUC = 0.8125).
- 可解释的ML方法证实了选定的预后因素的相关性.
结论:
- 一个可解释的Catboost模型包含8个变量,有效预测AITL患者的1年生存期.
- 这种基于ML的方法可以帮助临床医生进行风险分层和治疗规划.
- 这项研究强调了人工智能在改善血液恶性瘤的结果方面的潜力.
相关概念视频
Actuarial Approach
286
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
286
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Kaplan-Meier Approach
574
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
574


